---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-035114"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:45:02.560898+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.04
calibrated_materiality_score: 0.04
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics stockholders elect two Class II directors and ratify KPMG as auditor

## Summary
- Lawrence Alleva elected with 27,501,778 votes for, 3,359,405 withheld, 10,682,973 broker non-votes.
- Kevin Lokay elected with 27,504,038 votes for, 3,357,145 withheld, 10,682,973 broker non-votes.
- KPMG LLP ratified as independent auditor for FY2024 with 41,342,291 for, 184,580 against, 17,285 abstentions.
- Annual meeting held on February 24, 2025; all proposals approved by stockholders.

## SEC filing metadata
- accession: 0001193125-25-035114
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.04
- calibrated_materiality_score: 0.04
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312525035114/0001193125-25-035114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312525035114/d830385d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-035114
- JSON: https://secwatch.observer/filing/0001193125-25-035114.json
- Plain text: https://secwatch.observer/filing/0001193125-25-035114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.